Refractory Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
Drug | Drug Name | Drug Description |
---|---|---|
DB15102 | Pemigatinib | A kinase inhibitor used to treat locally advanced or metastatic, unresectable cholangiocarcinoma in previously treated adult patients. |
Drug | Drug Name | Phase | Status | Count |
---|